Immune effector cells produce lethal DNA damage in cells treated with a thiopurine

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2393-2399

  Daehn, Ilse ^a   Karran, Peter ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; REACTIVE OXYGEN METABOLITE; TIOGUANINE; ANTIOXIDANT; DNA; HYDROGEN PEROXIDE; OXIDIZING AGENT;

ARTICLE; CELL INFILTRATION; CELL LINE; COCULTURE; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE; OXIDATION; PRIORITY JOURNAL; TARGET CELL; ANIMAL; CELL STRAIN HCT116; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; CELL LINE; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; HCT116 CELLS; HUMANS; HYDROGEN PEROXIDE; MACROPHAGES; MICE; OXIDANTS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; THIOGUANINE;

EID: 65549103475     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4264     Document Type: Article

References (26)

1. Bernstein CK, Rlanehard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease. Cancer 2001;91:854-62.
2. Gaffney K, Scott DGI. Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis. Br J Rheumatol 1998;37:824-36.
3. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mereaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
4. Warren DJ, Andersen A, Slordal L. Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mereaptopu- rine-based maintenance therapy. Cancer Res 1995;55: 1670-4.
5. Cuffari C, Seidmen EG, Latour S, Theoret Y. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6- mercaptopurine therapy. Can j Physiol Pharmacol 1996; 74:580-5.
6. Lehmann AR. Replication of damaged DNA by translesion synthesis in human cells. FERS Lett 2005; 579:873-6.
7. O'Donovan P, Perrett C, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005;309:1871-4.
8. Zhang X, Jeffs G, Ren X, et al. Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light. DNA Repair 2006;6:344-54.
9. Perrett CM, Walker SL, O'Donovan P, et al. Azathioprine treatment sensitizes human skin to ultraviolet A radiation. Br J Dermatol 2008;159:198-204.
10. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997;11: 118-24.
11. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 2002;30: 227-32.
12. Seruga B, Zhang H, Bernstein Lj, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008;8:887-99.
13. Seril DK, Liao j, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24: 353-62.
14. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126:451-9.
15. Pick F. Microassays for superoxide and hydrogen peroxide production and nitrohlue tetrazolium reduction using an enzyme immunoassay mieroplate reader. Methods Enzymol 1986;132:407-21.
16. Friedherg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. DNA repair and mutagenesis. 2nd ed. Washington: ASM Press; 2006.
17. Vuillaume M, Calvayrac R, Best-Belpomme M, et al. Deficiency in the catalase activity of xeroderma pigmentosum cell and simian virus 40~txansformed human cell extracts. Cancer Res 1986;46:538-44.
18. Aarbakke J, Janka-Schaub G, Elion GB. Thiopurine biology and pharmacology. TIPS 1997;18:3-8.
19. Karran P, Attard N, Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 2008;8:24-36.
20. Swann PF Waters TR, Moulton DC, Xu Y-Z, Edwards M, Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 1996;273:1109-11.
21. Dijkstra G, Moshage H, van Dullemen HM, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.] Pathol 1998;186:416-21.
22. - production in neutrophils of Crohn's disease patients. Exp Biol Med 2006;231:186-95.
23. Eraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002;50:485-9.
24. Masunaga Y, Ohno K, Ogawa R, Hashiguchi M, Echizen H, Ogata H. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother 2007;41:21-8.
25. Shanahan F. Relation between colitis and colon cancer. Lancet 2001;357:246-7.
26. Matula S, Croog V, Itzkowitz S, et al. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol 2005;3: 1015-21.